CLOPIDOGREL- SPIRIT clopidogrel (as besilate) 75 mg film-coated tablet blister pack

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

clopidogrel besilate, Quantity: 111.86 mg (Equivalent: clopidogrel, Qty 75 mg)

Tilgængelig fra:

Medis Pharma Pty Ltd

INN (International Name):

clopidogrel besilate

Lægemiddelform:

Tablet, film coated

Sammensætning:

Excipient Ingredients: lactose; purified talc; glyceryl behenate; crospovidone; microcrystalline cellulose; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin

Indgivelsesvej:

Oral

Enheder i pakken:

28 tablets

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

Prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. Acute coronary syndrome: Clopidogrel is indicated in combination with aspirin for patients with: Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel is indicated for treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent). ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Produkt oversigt:

Visual Identification: Pink round biconvex film-coated tablet, engraved with "II" on one side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Registered

Autorisation dato:

2010-02-24